Explore the recent GST reforms in India, enhancing accessibility to healthcare products and services for everyone.
Significant GST revisions effective September 22, 2025, impact healthcare product pricing and services nationwide.
Health and life insurance premiums are now exempt from GST, previously at 18%.
GST on 33 essential life-saving drugs is reduced to NIL, improving affordability.
GST for three specific critical drugs now reduced from 5% to NIL for urgent needs.
General drugs and medicines see GST reduced from 12% to 5%, easing family healthcare costs.
GST on medical apparatus and devices drops from 18% to 5%, making them more accessible.
Supplies such as bandages and diagnostic kits now taxed lower at 5%, improving healthcare delivery.
Corrective spectacles now face a reduced GST of 5%, ensuring better vision for all.
Room rents above u20b95,000 per day remain at 5%, excluding critical care units.
These revisions aim to make healthcare services more affordable and accessible for everyone.